AEPCX
Price
$59.85
Change
+$0.41 (+0.69%)
Updated
Sep 8 closing price
Net Assets
133.49B
LAFGX
Price
$16.64
Change
+$0.30 (+1.84%)
Updated
Sep 8 closing price
Net Assets
3.69M
Interact to see
Advertisement

AEPCX vs LAFGX

Header iconAEPCX vs LAFGX Comparison
Open Charts AEPCX vs LAFGXBanner chart's image
American Funds EUPAC C
Price$59.85
Change+$0.41 (+0.69%)
VolumeN/A
Net Assets133.49B
Lord Abbett International Growth F
Price$16.64
Change+$0.30 (+1.84%)
VolumeN/A
Net Assets3.69M
AEPCX vs LAFGX Comparison Chart in %
Loading...
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 133B vs. LAFGX (3.69M). LAFGX pays higher dividends than AEPCX: LAFGX (0.32) vs AEPCX (0.16). AEPCX was incepted earlier than LAFGX: AEPCX (25 years) vs LAFGX (4 years). LAFGX (9.22) is less costly to investors than AEPCX (1.57). LAFGX is a more actively managed with annual turnover of: 88.00 vs. AEPCX (35.00). LAFGX has a lower initial minimum investment than AEPCX: LAFGX (0) vs AEPCX (250). LAFGX annual gain was more profitable for investors over the last year : 16.00 vs. AEPCX (7.59).
AEPCXLAFGXAEPCX / LAFGX
Total Expense Ratio1.570.70224%
Annual Report Gross Expense Ratio1.579.2217%
Fund Existence25 years4 years-
Gain YTD15.03819.10379%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets133B3.69M3,605,313%
Annual Yield % from dividends0.160.3251%
Returns for 1 year7.5916.0047%
Returns for 3 years32.6554.9159%
Returns for 5 years7.78N/A-
Returns for 10 years34.34N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IPSC0.500.03
+5.41%
Century Therapeutics
LOVE20.410.40
+2.00%
Lovesac Company (The)
STAA27.940.16
+0.58%
STAAR Surgical Company
RYTM102.12-2.45
-2.34%
Rhythm Pharmaceuticals
AMD151.14-10.65
-6.58%
Advanced Micro Devices